Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$73,350,653
New position
Shares Held
371,923
first reported quarter
Ownership
0.024%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Mariner, LLC holds $2,564,877,175 across 16 Drug Manufacturers - General names. AZN ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
693,861 | $638,192,529 | |
| 2 | JNJ |
Johnson & Johnson
|
1,928,325 | $471,359,760 | |
| 3 | AMGN |
Amgen Inc
|
1,076,357 | $378,716,208 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,795,221 | $336,237,132 | |
| 5 | ABBV |
AbbVie Inc.
|
1,316,270 | $286,275,561 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,744,281 | $105,790,640 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
621,970 | $86,683,958 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
371,923 | $73,350,653 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,350,653 | 371,923 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||